CR10291A - Vacuna de mycoplasma hyopneumoniae - Google Patents

Vacuna de mycoplasma hyopneumoniae

Info

Publication number
CR10291A
CR10291A CR10291A CR10291A CR10291A CR 10291 A CR10291 A CR 10291A CR 10291 A CR10291 A CR 10291A CR 10291 A CR10291 A CR 10291A CR 10291 A CR10291 A CR 10291A
Authority
CR
Costa Rica
Prior art keywords
mycoplasma hyopneumoniae
hyopneumoniae vaccine
vaccine
pigs
adjuvant
Prior art date
Application number
CR10291A
Other languages
English (en)
Inventor
Gregory Charles Royer
Russell Howser
Catherine Charreyre
Francis William Milward
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of CR10291A publication Critical patent/CR10291A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Una sola dosis de una vacuna que comprende Mycoplasma hyopneumoniae inactivado y un adyuvante, con un inyector sin aguja de chorro de liquido para inducir una respuesta inmune segura y protectora conta Mycoplasma hyopneumoniae en los cerdos.
CR10291A 2006-03-03 2008-09-17 Vacuna de mycoplasma hyopneumoniae CR10291A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77898706P 2006-03-03 2006-03-03

Publications (1)

Publication Number Publication Date
CR10291A true CR10291A (es) 2009-03-06

Family

ID=38475356

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10291A CR10291A (es) 2006-03-03 2008-09-17 Vacuna de mycoplasma hyopneumoniae

Country Status (13)

Country Link
US (1) US20080014221A1 (es)
EP (1) EP1991262A4 (es)
JP (1) JP2009528361A (es)
KR (1) KR20080100384A (es)
CN (1) CN101448521A (es)
AU (1) AU2007222016A1 (es)
BR (1) BRPI0708522A2 (es)
CA (1) CA2644195A1 (es)
CR (1) CR10291A (es)
EC (1) ECSP088787A (es)
GT (1) GT200800172A (es)
MX (1) MX2008011247A (es)
WO (1) WO2007103042A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
PE20120909A1 (es) * 2009-05-19 2012-08-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma
WO2011035267A1 (en) * 2009-09-18 2011-03-24 Orthocare Innovations Llc Self aligning prosthesis with hydraulic actuators
WO2011131789A1 (en) * 2010-04-23 2011-10-27 Intervet International B.V. A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5
EP2569007B1 (en) 2010-05-11 2015-10-14 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
DK2609428T3 (en) * 2010-08-27 2016-05-17 Intervet Int Bv STRENGTH TEST FOR VACCINE FORMULATIONS
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
ES2674439T3 (es) * 2011-06-01 2018-06-29 Merial, Inc. Administración sin aguja de vacunas contra el VSRRP
CN103018442B (zh) * 2011-09-23 2014-11-19 华中农业大学 猪肺炎支原体间接elisa抗体检测试剂盒及应用
CN103182076B (zh) * 2011-12-29 2015-06-17 北京大北农科技集团股份有限公司 一种猪支原体肺炎灭活疫苗及其制备方法
AR089995A1 (es) * 2012-02-14 2014-10-01 Merial Ltd Vacunas de subunidades de rotavirus, metodos de preparacion y uso de las mismas
CN102735851B (zh) * 2012-07-13 2014-12-31 江苏省农业科学院 一种猪肺炎支原体多重组抗原elisa检测试剂盒
HUE059179T2 (hu) * 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
CN103585622B (zh) * 2013-11-25 2015-09-02 江苏省农业科学院 猪支原体肺炎疫苗株的应用
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
CN108601824A (zh) * 2015-12-28 2018-09-28 梅里亚股份有限公司 M Hyo多价疫苗及其用途
CN105999259A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射狂犬病疫苗系统与应用
CN105999257A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射流感疫苗系统与应用
CN105854010A (zh) * 2016-05-11 2016-08-17 长春海基亚生物技术股份有限公司 无针注射手足口病疫苗系统与应用
US10519199B2 (en) * 2016-08-12 2019-12-31 Innovac Vaccine composition comprising recombinant protein for preventing swine Mycoplasma infection
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029457B2 (en) * 1999-11-23 2006-04-18 Felton International, Inc. Jet injector with hand piece
BR0210804A (pt) * 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
WO2005009462A2 (en) * 2003-07-24 2005-02-03 Merial Limited Vaccine formulations comprising an oil-in-water emulsion
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations

Also Published As

Publication number Publication date
KR20080100384A (ko) 2008-11-17
AU2007222016A1 (en) 2007-09-13
MX2008011247A (es) 2008-09-11
CN101448521A (zh) 2009-06-03
EP1991262A4 (en) 2009-11-04
BRPI0708522A2 (pt) 2011-05-31
US20080014221A1 (en) 2008-01-17
GT200800172A (es) 2010-05-07
EP1991262A2 (en) 2008-11-19
CA2644195A1 (en) 2007-09-13
WO2007103042A2 (en) 2007-09-13
WO2007103042A3 (en) 2009-02-05
ECSP088787A (es) 2008-11-27
JP2009528361A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
CR10291A (es) Vacuna de mycoplasma hyopneumoniae
CR11122A (es) Vacuna de influenza de emulsion de aceite en agua
CO6331298A2 (es) Vacunas contra coccidiosis
ECSP10010723A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso
CL2015001111A1 (es) Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna.
CR10726A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua
BR112015009189A2 (pt) conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo
CL2012001215A1 (es) Sistema de expresion de un vector que comprende un primer y un segundo cassete de expresion donde el primer cassete codifica una gtp-ciclohidrolasa (gch1) y el segundo codifica una tirosina hidrolasa; vector; celula hospedera; uso del vector para preparar medicamento para tratar enfermedad asociada con catecolamina.
CL2015002513A1 (es) Vacuna acelular contra pertussis
CL2008003304A1 (es) Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae.
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
RS52188B (en) A PSYCHI VACCINE FOR THE PROTECTION OF ERLIHIOSIS
PE20211545A1 (es) Dosis unitaria de vacuna contra el dengue y administracion de esta
CO6561819A2 (es) Vectores para vacunas y método para potenciar respuestas inmunes
ES2531018T3 (es) Vacuna contra la tuberculosis y método de uso de la misma
He et al. Immunological synergistic mechanisms of trans-/cis-stilbene glycosides in Heshouwu-related idiosyncratic liver injury
CL2015003666A1 (es) Un sistema de almacenamiento de energía para un uso con una caldera de combinación, que comprende una pluralidad de bancos de almacenamiento de energía térmica, un dispositivo de extracción, y un controlador
AR090450A1 (es) Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteina c mutada y usos de la misma
CO2019004814A2 (es) Terapias combinadas para la ateroesclerosis, incluyendo la enfermedad cardiovascular ateroesclerótica
AR089995A1 (es) Vacunas de subunidades de rotavirus, metodos de preparacion y uso de las mismas
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
AR063882A1 (es) Vacuna canina leishmania
AR093424A1 (es) Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso
Lucarelli et al. AGILE confirmation of enhanced gamma-ray activity from NGC 1275
AR105792A2 (es) Método para el tratamiento de biomasa

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)